About Suburban Diagnostics (India) Private Limited
Data last updated:
Suburban Diagnostics (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Dr. Lal Pathlabs Limited. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 06 June 2002.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85110MH2002PTC136144. Its GSTIN is 27AAGCS3852D1ZE (Maharashtra).
The company has an authorised share capital of ₹16.09 Cr and a paid-up capital of ₹4.03 Cr. It is led by directors including Shankha Banerjee and Ved Prakash Goel.
Its last annual general meeting (AGM) was held on 28 June 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹170.87 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹11.73 Cr (net margin 6.9%) and EBITDA of ₹27.57 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 3% over five years.
The company has about 754 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹41.15 Cr on record. Court records list 24 cases involving the company, including 24 filed by the company; 22 cases are pending. The company has 11 deals on record (6 secondary share transfers, 4 funding rounds, 1 debt financing), with disclosed funding of ₹80.25 Cr; the latest was in March 2022. Its 5 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.) are compared by revenue, 3 larger and 2 smaller; the largest is Sterling Accuris Wellness Private Limited with revenue of ₹201.83 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2021, listing 58 overdue payments to 15 micro and small suppliers.
The last known website on record is suburbandiagnostics.com.
Company details
Contact details
Suburban Diagnostics (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is suburbandiagnostics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2nd Floor Aston Sundervan Complex Lokhandwala Road, Andheri (West) India, Mumbai, Maharashtra, India – 400053
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Suburban Diagnostics (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Suburban Diagnostics (India) is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Suburban Diagnostics (India) Private Limited, buy the company report.
Financials of Suburban Diagnostics (India) Private Limited
FY 2024 filings availableSuburban Diagnostics (India) Private Limited reported revenue of ₹170.87 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 7% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹170.87 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suburban Diagnostics (India) Private Limited, buy the company report.
Board of directors of Suburban Diagnostics (India) Private Limited
Suburban Diagnostics (India) has 4 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shankha Banerjee Also directs: Paliwal Diagnostics Private Limited, Centrapath Labs Private Limited, Dr. Lal Ventures Private Limited and 3 more | Director | 12 Nov 2021 | 4 Years 11 Months | As last reported |
| Ved Prakash Goel Also directs: Paliwal Diagnostics Private Limited, Asv Associates Private Limited, Ofb Tech Limited and 5 more | Director | 12 Nov 2021 | 4 Years 11 Months | As last reported |
| Vandana Lal | Director | 12 Nov 2021 | 4 Years 11 Months | As last reported |
| Dilipkumar Natvarlal Jagad Also directs: Excel Restructuring Advisory LLP | Irp/Rp/Liquidator | 11 Feb 2025 | 1 Years 8 Months | As last reported |
Peer comparison
Suburban Diagnostics (India) Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sterling Accuris Wellness Private Limited | ₹201.83 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India | |||
| Unipath Specialty Laboratory Limited | ₹183.41 Cr (FY 2024) | 23.0% | Ahmedabad, Gujarat, India | |||
| Tenet Medcorp Private Limited | ₹182.46 Cr (FY 2025) | 30.0% | Hyderabad, Telangana, India | |||
| Suburban Diagnostics (India) Private Limitedthis company | ₹170.87 Cr (FY 2024) | ₹11.73 Cr | 6.9% | 7.0% | 754 | Mumbai, Maharashtra, India |
| Max Lab Limited | ₹168.61 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Mahajan Imaging Private Limited | ₹156.25 Cr (FY 2025) | 4.0% | Delhi, India |
To see the full peer comparison of Suburban Diagnostics (India) Private Limited, buy the company report.
Auditor
Suburban Diagnostics (India) Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2024 | 117366W/W-100018 |
Shareholding
The shareholding of Suburban Diagnostics (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Suburban Diagnostics (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jan 2018 | 100210215 | Others | ₹49.45 Lakh | Satisfied | |
| 19 Dec 2015 | 10619190 | Innoven Capital India Private Limited | ₹3.25 Cr | Satisfied | |
| 19 Nov 2015 | 10604993 | Others | ₹13.76 Cr | Satisfied | |
| 31 Jul 2014 | 10515911 | Siemens Financial Services Private Limited | ₹1.27 Cr | Satisfied | |
| 16 Jun 2014 | 10510506 | Siemens Financial Services Private Limited | ₹22.1 Lakh | Satisfied |
To see the full charge records of Suburban Diagnostics (India) Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Suburban Diagnostics (India) Private Limited has 11 deals on record (6 secondary share transfers, 4 funding rounds, 1 debt financing), with disclosed funding of ₹80.25 Cr; the latest was in March 2022.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Dr. Lal Pathlabs Limited , Dr. Lal Pathlabs Limited & Shankha Banerjee Seller: 4 individuals |
| Nov 2021 | Secondary share transfer | Undisclosed | Buyer: Dr. Lal Pathlabs Limited Seller: Peak XV Partners (Sequoia India and SEA) |
| Nov 2021 | Secondary share transfer | Undisclosed | Buyer: Dr. Lal Pathlabs Limited Seller: Peak XV Partners (Sequoia India and SEA), 2 individuals |
| Dec 2015 | Debt financing | ₹3.25 Cr | Investors: InnoVen Capital |
| Dec 2014 | Funding round · Series B | ₹11.5 Cr | Investors: Peak XV Partners (Sequoia India and SEA), an individual |
To see the full deal history of Suburban Diagnostics (India) Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Suburban Diagnostics (India) Private Limited has 24 court cases on record: 24 filed by Suburban Diagnostics (India). 22 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 0 | 22 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed by the company against Vittals Medicare Pvt. Ltd. | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Vittals Medicare Pvt Ltd and 2 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Aum Healthcare Ventures LLP and Others and 2 others | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed by the company against an individual | Pending |
To see the full case history of Suburban Diagnostics (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Suburban Diagnostics (India) Private Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 58 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bio-Lab (India) | |||
| an individual supplier | |||
| Sekhmet Technologies Private Limited | |||
| Silicon Netsecure Private Limited | |||
| Pragmasys Consulting LLP |
To see the full MSME payment records of Suburban Diagnostics (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Suburban Diagnostics (India) Private Limited has a workforce of 754 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
GST
Suburban Diagnostics (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCS3852D1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Suburban Diagnostics (India) Private Limited, buy the company report.
Recent activity
Suburban Diagnostics (India) Private Limited has 15 board changes on record since 2012: 4 appointments and 11 cessations. The latest: Dilipkumar Natvarlal Jagad was appointed as Irp/Rp/Liquidator on 11 Feb 2025.
42 earlier events are in the company report.
Frequently asked questions
Suburban Diagnostics (India) is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Suburban Diagnostics (India) is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 06 June 2002 and is registered under CIN U85110MH2002PTC136144. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Suburban Diagnostics (India) has 4 current directors:
- Shankha Banerjee - Director
- Ved Prakash Goel - Director
- Vandana Lal - Director
- Dilipkumar Natvarlal Jagad - Irp/Rp/Liquidator
The latest financial statements of Suburban Diagnostics (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 June 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Suburban Diagnostics (India) is U85110MH2002PTC136144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suburban Diagnostics (India) has no open charges and satisfied charges of ₹41.15 Cr as per latest MCA filings.
Suburban Diagnostics (India) has 24 court cases on record: 24 filed by the company. 22 are pending. Most are in the district courts.
Suburban Diagnostics (India) was incorporated on 06 June 2002. It is registered with the Registrar of Companies, Mumbai.
Suburban Diagnostics (India) has 11 deals on record (6 secondary share transfers, 4 funding rounds, 1 debt financing), with disclosed funding of ₹80.25 Cr; the latest was in March 2022.
The peers of Suburban Diagnostics (India) by revenue are Sterling Accuris Wellness Private Limited, Unipath Specialty Laboratory Limited, Tenet Medcorp Private Limited, Max Lab Limited, Mahajan Imaging Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Dilipkumar Natvarlal Jagad was appointed as Irp/Rp/Liquidator on 11 Feb 2025. Ishaan Mittal ceased to be Nominee Director on 12 Nov 2021. Ravi Shankar Venkataraman Ganapathy Agraharam ceased to be Director on 12 Nov 2021. Suburban Diagnostics (India) has 15 board changes on record in total.
Suburban Diagnostics (India) has 4 MSME Form 1 returns on record between 2019 and 2021, listing 58 overdue payments to 15 micro and small suppliers. The latest return was filed on 18 Jan 2022.